Marina Brodsky - Concepedia

Author

Marina Brodsky

Pfizer (United States)

Also Known As

M BRODSKY, M Brodsky, M. Brodsky, Marina Brodsky

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Cornell University Sunnybrook Health Science Centre Memorial Sloan Kettering Cancer Center University of Toronto

About

Marina Brodsky is an author at Pfizer (United States) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	666
2	Health Sciences	6	6	199
3	Neuroscience	5	5	179
4	Anesthesia	2	2	96
5	Neurology	1	1	20

Marina Brodsky

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder Christopher R. Chapple, Philip Van Kerrebroeck, Andrea Tubaro, European Urology Once-daily FesoterodineUrological ResearchUrologyVoiding DysfunctionMedicine	2007	237
Efficacy, Safety and Tolerability of Fesoterodine for Overactive Bladder Syndrome Victor W. Νitti, Roger R. Dmochowski, Peter K. Sand, The Journal of Urology	2007	187
Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers Christopher R. Chapple, Sender Herschorn, Paul Abrams, European Urology Urological ResearchUrologyVoiding DysfunctionMedicineStorage Symptoms Suggestive	2008	174
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial Sender Herschorn, Steven Swift, Zhonghong Guan, British Journal of Urology	2009	159
Comparison of fesoterodine and tolterodine in patients with overactive bladder Christopher R. Chapple, Philip E.V. van Kerrebroeck, Klaus‐Peter Jünemann, British Journal of Urology	2008	87
Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c- fos mRNA Kathryn Elliott, Marina Brodsky, Alexandra Hynansky, Pain Pain MedicineMolecular PainFormalin NociceptionFormalin-induced IncreasePain Management	1995	76
CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone Marina Brodsky, Kathryn Elliott, Alexandra Hynansky, Brain Research Bulletin	1995	62
Expression of the adrenergic phenotype in cultured fetal adrenal medullary cells: Role of intrinsic and extrinsic factors Gladys Teitelman, Tong H. Joh, D. Park, Developmental Biology Adrenal GlandDevelopmental BiologyPhysiologyAdrenal HealthNeuroendocrine Mechanism	1982	56
NMDA antagonists and clonidine block c‐fos expression during morphine withdrawal Kurt Rasmussen, Marina Brodsky, Charles E. Inturrisi Synapse	1995	43
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo Philip E.V. van Kerrebroeck, Con Kelleher, Karin S. Coyne, Health and Quality of Life Outcomes	2009	38

Page 1